Annals of Clinical Psychiatry

, Volume 15, Issue 2, pp 109–119 | Cite as

Ginkgo biloba Extract: Review of CNS Effects

Article

Abstract

The marketing of Ginkgo biloba extract (GBE) products is directed to the healthy, not diseased, population primarily for the promotion and maintenance of optimal brain function, not the treatment or prevention of any specific pathological state. However, recommendations are available for the use of GBE for a myriad of diseases that generally fall into one of three categories—cerebrovascular, peripheral vascular, or mitigation of tissue damage. The evidence for the pharmacological actions of GBE stem from one of three types of investigations—clinical studies in humans, pharmacological trials in animals, and in vitro studies. The purpose of this paper is to review the scientific literature on the central nervous system effects of GBE, with emphasis on the potential mechanisms of action. Limitations of the current scientific literature are highlighted and suggestions for future human and animal research directions are proposed.

Ginkgo biloba extract EGb 761 aging 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA 2002; 287(3):337-344Google Scholar
  2. 2.
    Anonymous: PDR for Herbal Medicines: Ginkgo biloba. 1st edn. Montvale, NJ: Medical Economics Co; 1998:871-873Google Scholar
  3. 3.
    Tyler VE: The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, 3rd edn. New York: Pharmaceutical Products Press; 1993:149-151Google Scholar
  4. 4.
    Wincor MZ: Ginkgo biloba for dementia: A reasonable alternative? JAPhA 1999; 39(3):415-416Google Scholar
  5. 5.
    Chen C, Wei T, Gao Z, Zhao B, Hou J, Xu H, Xin W, Packer L: Different effect of the constituents of EGb761 on apoptosis in rat cerebellar granual cells induced by hydroxyl radicals. Biochem Mol Biol Int 1999; 47(3):397-405Google Scholar
  6. 6.
    Bedir E, Tatli II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan IA: Biologically active secondary metabolites from Ginkgo biloba. J Agric Food Chem 2002; 50:3150-3155Google Scholar
  7. 7.
    Sasaki K, Oota I, Wada K, Inomata K, Ohshika H, Haga M: Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices. Comp Biochem Physiol C 1999; 124:315-321Google Scholar
  8. 8.
    Sasaki K, Hatta S, Haga M, Ohshika H: Effects of bilobalide on γ-aminobutyric acid levels and glutamic acide decarboxylase in mouse brain. Eur J Pharmacol 1999; 367:165-173Google Scholar
  9. 9.
    Chandrasekaran K, Mehrabian Z, Spinnewyn B, Drieu K, Fiskum G: Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res 2001; 922:282-292Google Scholar
  10. 10.
    Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A: Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Biochem Pharmacol 2002; 63:1241-1249Google Scholar
  11. 11.
    Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PKT, Coutts RT: Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 2000; 52:451-459Google Scholar
  12. 12.
    McKenna DJ, Jones K, Hughes K: Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001; 7(5):70-90Google Scholar
  13. 13.
    Youdim KA, Joseph JA: A possible emerging role of phytochemicals in improving age-related neurological dysfunction: A multiplicity of effects. Free Radical Biol Med 2001; 30(6):583-594Google Scholar
  14. 14.
    Alaoui-Youssefi A, Lamproglou I, Drieu K, Emerit I: Anticlastogenic effects of Ginkgo biloba extract (EGb 761) and some of its constituents in irradiated rats. Mutat Res 1999; 445:99-104Google Scholar
  15. 15.
    Nathan P: Can the cognitive enhancing effects of Ginkgo biloba be explained by its pharmacology?. Med Hypotheses 2000; 55(6):491-493Google Scholar
  16. 16.
    LeBars PL, Kieser M, Itil KZ: A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 2000; 11:230-237Google Scholar
  17. 17.
    Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, eds.: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998:136-138Google Scholar
  18. 18.
    Klepser TB, Klepser ME: Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999; 56:125-138Google Scholar
  19. 19.
    Kleijnen J, Knipschild P: Ginkgo biloba. Lancet 1992; 340:1136-1139Google Scholar
  20. 20.
    Chavez ML, Chavez PI: Ginkgo (Part 2): Clinical efficacy, dosage, and adverse effects. Hosp Pharm 1998; 33(9):1076-1095Google Scholar
  21. 21.
    Vaes LPJ, Chyka PA: Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: Nature of the evidence. Ann Pharmacotherapy 2000; 34:1478-1482Google Scholar
  22. 22.
    Miller LG: Herbal medicines. Arch Intern Med 1998; 158(9):2200-2211Google Scholar
  23. 23.
    Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355:134-138Google Scholar
  24. 24.
    Maclennan KM, Darlington CL, Smith PF: The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiology 2002; 67:235-257Google Scholar
  25. 25.
    Gohil K: Genomic responses to herbal extracts: lessons from in vitro and in vivo studies with an extract of Ginkgo biloba. Biochem Pharmacol 2002; 64:913-917Google Scholar
  26. 26.
    Itil TM, Eralp E, Tsambis E, Itil KZ, Stein U: Central nervous system effects of Ginkgo biloba, a plant extract. Am J Therap 1996; 3:63-73Google Scholar
  27. 27.
    Itil T, Martorano D: Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmcol Bull 1995; 31(1):147-158Google Scholar
  28. 28.
    Rigney U, Kimber S, Hindmarch I: The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother Res 1999; 13:408-415Google Scholar
  29. 29.
    Allain H, Raoul P, Lieury A, LeCoz F, Gandon JM: Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993; 15:549-558Google Scholar
  30. 30.
    Sudhon Z, Hindmarch I: The pharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharmacol Res 1984; 4(2):89-93Google Scholar
  31. 31.
    Hindmarch SZ:The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharm Res 1984; IV:89-93Google Scholar
  32. 32.
    Kennedy DO, Scholey AB, Wesnes KA: The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology 2000; 151:416-423Google Scholar
  33. 33.
    Kennedy DO, Scholey AB, Wesnes KA: Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/Panax ginseng combination to healthy young volunteers. Nutr Neurosci 2001; 4:399-412Google Scholar
  34. 34.
    Wesnes KA, Ward T, McGinty A, Petrini O: The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000; 152:353-361Google Scholar
  35. 35.
    Mix JA, Crews WD: An examination of the efficacy of Ginkgo biloba extract EGB 761 on the nueropsychologic functioning of cognitively intact older adults. J Altern Complementary Med 2000; 6(3):219-229Google Scholar
  36. 36.
    Stough C, Clarke J, Lloyd J, Nathan PJ: Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. Int J Neuropsychopharmacol 2001; 4:131-134Google Scholar
  37. 37.
    Moulton PL, Boyko LN, Fitzpatrick JL, Petros TV: The effect of Ginkgo biloba on memory in healthy male volunteers. Physiol Behav 2001; 73:659-665Google Scholar
  38. 38.
    Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R: Ginkgo for memory enhancement: A randomized controlled trial. JAMA 2002; 288(7):835-840Google Scholar
  39. 39.
    Ernst E, Pittler MH: Ginkgo biloba for dementia: A systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17(4):301-308Google Scholar
  40. 40.
    Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R: Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of alzheimer type or multi-infarct dementia. Pharmacopsychiatria 1996; 29:47-56Google Scholar
  41. 41.
    Maurer K, Ihl R, Dierks T, Frolich L: Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 1997; 31(6):645-655Google Scholar
  42. 42.
    Winther K, Randlov C, Rein E, Mehlsen J: Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Curr Therap Res 1998; 59(12):881-888Google Scholar
  43. 43.
    LeBars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg A: A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278:1327-1332Google Scholar
  44. 44.
    Wettstein A: Cholinesterase inhibitors and Ginkgo extracts—are they comparable in the treatment of dementia? Phytomedicine 2000; 6(6):393-401Google Scholar
  45. 45.
    Curtis-Prior C, Vere D, Fray P: Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 1999; 51:535-541Google Scholar
  46. 46.
    LeBars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R: Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGB 761® in Alzheimer's disease. Neuropsychobiology 2002; 45:19-26Google Scholar
  47. 47.
    Van Dongen MCJM, van Rossum E, Kessels AGH, Sielhorst HJG, Knipschild PG: The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000; 48:1183-1194Google Scholar
  48. 48.
    Agnoli A, Fiorani P, Pistolese GR: Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of Ginkgo biloba. Minerva Med 1973; 64(79 Suppl):4166-4173Google Scholar
  49. 49.
    Barker PB, Yousem DM: Reproducibility of MR perfusion imaging with GdDTPA: Effect of Ginkgo biloba. Proc Intl Soc Mag Reson Med 2000; 8:1272Google Scholar
  50. 50.
    Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Watkins GL, Ponto LLB, Hichwa RD: II. PET studies of memory: Novel versus practiced free recall of word lists. Neuroimage 1995; 2:296-305Google Scholar
  51. 51.
    Schweizer J, Hautmann C: Comparison of two dosages of Ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's Stage IIb. Arzneim-Forsch/Drug Res 1999; 49(II):900-904Google Scholar
  52. 52.
    Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R: Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Therap 1999; 15(3):233-240Google Scholar
  53. 53.
    Krieglstein J, Beck T, Seibert A: Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 1986; 39:2327-2334Google Scholar
  54. 54.
    Zhang WR, Hayashi T, Kitagawa H, Sasaki C, Sakai K, Warita H, Wang JM, Shiro Y, Uchida M, Abe K: Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res 2000; 22:517-521Google Scholar
  55. 55.
    Rapin JR, Lafitte ML: Local cerebral glucose consumption: Effects of Ginkgo biloba extract. La Presse Medicale 1986; 15(31):1494-1497Google Scholar
  56. 56.
    Loffler T, Lee SK, Noldner M, Chatterjee SS, Hoyer S, Schliebs R: Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brains. J Neural Transm 2001; 108:1457-1474Google Scholar
  57. 57.
    Duverger D, Defeudis FV, Drieu K: Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) on cerebral glucose utilization in the rat: an autoradiographic study. Gen Pharac 1995; 26(6):1375-1383Google Scholar
  58. 58.
    Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J: Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: Protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33:7-11Google Scholar
  59. 59.
    Kurtsoy A, Canbay S, Oktem IS, Akdemir H, Koc RK, Menku A, Tucer B: Effect of EGb-761 on vasospasm in experimental subarachnoid hemorrhage. Res Exp Med 2000; 199:207-215Google Scholar
  60. 60.
    Cheung F, Siow YL, Chen WZ, Karmin O: Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem Pharmacology 1999; 58:1665-1673Google Scholar
  61. 61.
    Varga E, Bodi A, Ferninandy P, Droy-Lefaiz MT, Blasig IE, Tosaki A: The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: A link between cardiac function and nitric oxide production. J Cardiovascular Pharmacol 1999; 34:711-717Google Scholar
  62. 62.
    Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM: Ginkgo biloba extract (EGb 761) protects Na, K-ATPase activity during cerebral ischemia in mice. NeuroReport 1999; 10:47-51Google Scholar
  63. 63.
    Wei T, Ni Y, Hou J, Chen C, Zhao B, Xin W: Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: Protection by ginkgo biloba extract. Pharmacol Res 2000; 41(4):427-433Google Scholar
  64. 64.
    Wei Z, Peng Q, Lau BHS, Shah V: Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. Gen Pharmacol 1999; 33:369-375Google Scholar
  65. 65.
    Welt K, Weiss J, Koch S, Fitzl G: Protective effects of Ginkgo biloba extract EGb 761 on the myocaridum of experiemtnally diabetic rats. Exp Toxic Pathol 1999; 51:213-222Google Scholar
  66. 66.
    Punkt K, Psinia I, Welt K, Barth W, Asmussen G: Effects on skeletal muscle fibres of diabetes and Ginkgo biloba extract treatment. Acta histochem 1999; 101:53-69Google Scholar
  67. 67.
    Du G, Willet K, Mouithys-Michalad A, Sluse-Goffart CM, Droy-Lefaix MT, Sluse FE: EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation. Free Radical Biol Med 1999; 27(5/6):596-604Google Scholar
  68. 68.
    Janssens D, Remacle J, Drieu K, Michiels C: Protection of mitochondrial respiration activity by bilobalide. Biochem Pharmacol 1999; 58:109-119Google Scholar
  69. 69.
    Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA: Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 2002; 70:357-360Google Scholar
  70. 70.
    Schindowski K, Leutner S, Kressmann S, Eckert A, Muller WE: Age-related increase of oxidative stress-induced apoptosis in mice: Prevention by Ginkgo biloba extract (EGb761). J Neural Transm 2001; 108:969-978Google Scholar
  71. 71.
    Trovero F, Brochet D, Tassin JP, Drieu K: Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptors. Brain Res 1999; 818:135-139Google Scholar
  72. 72.
    Weichel O, Hilgert M, Chatterjee SS, Lehr M, Klein J: Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phosphalipase A2 activation and phospholipid breakdown in rat hippocampus. Nauyn-Schmiedeberg's Arch Pharmacol 1999; 360:609-615Google Scholar
  73. 73.
    Bastianetto S, Zheng WH, Quirion R: The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J Neurochem 2000; 74:2268-2277Google Scholar
  74. 74.
    Calapai G, Crupi A, Firenzuoli F, Marciano MC, Squadrito F, Inferrera G, Parisi A, Rizzo A, Crisafulli C, Fiore A, Caputi AP: Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000; 67:2673-2683Google Scholar
  75. 75.
    Yao ZX, Drieu K, Szweda LI, Papadopoulos V: Free radical and lipid peroxidation do not mediate β-amyloid-induced neuronal cell death. Brain Res 1999; 847:203-210Google Scholar
  76. 76.
    Yao Zx, Drieu K, Papadopoulos V: The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β amyloid-induced cell death by inhibiting the formation of β amyloid-derived diffusible neurotoxic ligands. Brain Res 2001; 889:181-190Google Scholar
  77. 77.
    Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R: The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β amyloid. Eur J Neurosci 2000; 12:1882-1890Google Scholar
  78. 78.
    Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, Khan I, Netzer WJ, Xu H, Butko P: Inhibition of amyloid-b aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. PNAS 2002; 99(19):12197-12202Google Scholar
  79. 79.
    Gajewski A, Hensch SA: Ginkgo biloba and memory for a maze. Psychol Rep 1999; 84:481-484Google Scholar
  80. 80.
    Wirth S, Stemmelin J, Will B, Christen Y, Di Scala G: Facilitative effects of EGb 761 on olfactory recognition in young and aged rats. Pharmacol Biochem Behav 2000; 65(2):321-326Google Scholar
  81. 81.
    Winter JC, Timineri D: The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol Biochem Behav 1999; 62(3):543-547Google Scholar
  82. 82.
    Wu WR, Zhu XZ: Involvement of monamine oxidase inhibition in neuroprotective and neurorestorative effect of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 1999; 65(2):157-164Google Scholar
  83. 83.
    Pardon MC, Joubert C, Perez-Diaz F, Christen Y, Launay JM, Cohen-Salmon C: In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761). Mech Ageing Dev 2000; 113:157-168Google Scholar
  84. 84.
    Porsolt RD, Roux S, Drieu K: Evaluation of a Ginkgo biloba extract (EGb 761) in functional tests for monamine oxidase inhibition. Arzneim-Forsch/Drug Res 2000; 50(I):232-235Google Scholar
  85. 85.
    Fowler JS, Wang G-J, Volkow ND, Logan J, Franceschi D, Franceschi M, MacGregor R, Shea C, Garza V, Liu N, Ding YS: Evidence that Ginkgo biloba extract does not inhibit MAO A and B in living human brain. Life Sci 2000; 66(9):141-146Google Scholar
  86. 86.
    Larrabee GJ, McEntee WJ: Age associated memory impairment: Sorting out the controversies. Neurology 1995; 45:611-614Google Scholar

Copyright information

© American Academy of Clinical Psychiatrists 2003

Authors and Affiliations

  1. 1.Department of Radiology, Positron Emission Tomography Imaging Center, Roy J. and Lucille A. Carver College of MedicineUniversity of IowaIowa City
  2. 2.Department of Psychiatry, Positron Emission Tomography Imaging Center, Roy J. and Lucille A. Carver College of MedicineUniversity of IowaIowa City

Personalised recommendations